Borderline ovarian tumors: a review of treatment.
Borderline ovarian tumors have an excellent prognosis. In stage I disease, no therapy in addition to surgery is needed, and conservation of ovarian tissue for future childbearing may be appropriate. In advanced stages, the use of adjuvant therapy has not consistently led to cures, and complications have been reported. A randomized study of no adjuvant therapy versus adjuvant treatment with long-term follow-up will be necessary to determine the efficacy of additional treatment.
Chambers
J T
JT
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510.
D000230:Adenocarcinoma / Q000601:surgery*; D002288:Adenocarcinoma, Mucinous / Q000601:surgery*; D001948:Brenner Tumor / Q000601:surgery*; D002291:Carcinoma, Papillary / Q000601:surgery*; D003131:Combined Modality Therapy; D004715:Endometriosis / Q000601:surgery*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000601:surgery*; D011230:Precancerous Conditions / Q000601:surgery*